Found 3 results
Author Title [ Type(Asc)] Year
Filters: Author is Sarwar, UN  [Clear All Filters]
Journal Article
R. Seder, Chang, L., Enama, M., Zephir, K., Sarwar, U. N., Gordon, I., Holman, L., James, E., Billingsley, P., Gunasekera, A., Richman, A., Chakravarty, S., Manoj, A., Velmurugan, S., Li, M., ,, Sim, B., Ledgerwood, J., Graham, B., Hoffman, S., and Team, T. V. R. C. 312 St, “Protection Against Malaria by Intravenous Immunization With A Non-Replicating Sporozoite Vaccine”, Science, vol. 341, pp. 1359-1365, 2013.
U. N. Sarwar, Novik, L., Enama, M. E., Plummer, S. A., Koup, R. A., Nason, M. C., Bailer, R. T., McDermott, A. B., Roederer, M., ,, Ledgerwood, J. E., Graham, B. S., and Team, T. V. R. C. 015 St, “Homologous Boosting with Adenoviral Serotype 5 HIV Vaccine (rAd5) Vector Can Boost Antibody Responses Despite Preexisting Vector-Specific Immunity in a Randomized Phase I Clinical Trial”, PLoS One, vol. 9, p. e106240, 2014.
Conference Paper
J. E. Ledgerwood, Yamschikov, G., Enama, M. E., Sarwar, U. N., Bailer, R. T., Larkin, B., Bellamy, A. R., Anderson, E. L., Bernstein, D. I., Creech, B., Keyserling, H., Spearman, P., Wright, P., and Graham, B., “VRC 702: A Multicenter Phase 1 Study of Seasonal Influenza DNA Vaccine Prime Followed by the Trivalent Inactivated Vaccine (TIV) Compared to TIV-TIV in Children and Adolescents Ages 6-17 Years”, in 2014 Annual Conference on Vaccine Research, Bethesda, MD, 2014.